Correlation Between Anika Therapeutics and ProSomnus, Common

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and ProSomnus, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and ProSomnus, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and ProSomnus, Common Stock, you can compare the effects of market volatilities on Anika Therapeutics and ProSomnus, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of ProSomnus, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and ProSomnus, Common.

Diversification Opportunities for Anika Therapeutics and ProSomnus, Common

0.0

Correlation Coefficient

Anika Therapeutics  ProSomnus, Common

Pay attention - limited upside

The 3 months correlation between Anika and ProSomnus, is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and ProSomnus, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProSomnus, Common Stock and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with ProSomnus, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProSomnus, Common Stock has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and ProSomnus, Common go up and down completely randomly.

Pair Corralation between Anika Therapeutics and ProSomnus, Common

If you would invest  1,718  in Anika Therapeutics on November 20, 2024 and sell it today you would earn a total of  68.00  from holding Anika Therapeutics or generate 3.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Anika Therapeutics  vs.  ProSomnus, Common Stock

Anika Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Anika Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward indicators, Anika Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

ProSomnus, Common Stock

Risk-Adjusted Performance

Very Weak

Over the last 90 days ProSomnus, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ProSomnus, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Anika Therapeutics and ProSomnus, Common

The main advantage of trading using opposite Anika Therapeutics and ProSomnus, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, ProSomnus, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProSomnus, Common will offset losses from the drop in ProSomnus, Common's long position.

The idea behind Anika Therapeutics and ProSomnus, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.